North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

1. Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.Drug safety · 2003
   Pooled it
2. A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2002
   Trial
3. Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.BMJ (Clinical research ed.) · 2000
   Trial
4. Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.British journal of clinical pharmacology · 2000
   Trial
5. Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands.Drug safety · 2011
   Article
6. Best practice in primary care pathology: review 6.Journal of clinical pathology · 2007
   Review
7. Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract.Postgraduate medical journal · 2005
   Review
8. Methodology for constructing guidance.Journal of clinical pathology · 2005
   Article
9. Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.Therapeutics and clinical risk management · 2005
   Article
10. Clinical practice guidelines: towards better quality guidelines and increased international collaboration.British journal of cancer · 2003
    Article
11. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.Drugs · 2002
    Review
12. The barriers to effective management of heart failure in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2001
    Article
13. Role of the angiotensin II receptor blocker valsartan in heart failure.Experimental and clinical cardiology · 2001
    Article
14. Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project.Quality in health care : QHC · 2000
    Article
15. Lisinopril: a review of its use in congestive heart failure.Drugs · 2000
    Review
16. Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient.BMJ (Clinical research ed.) · 1999
    Article
17. Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.BMJ (Clinical research ed.) · 1999
    Article
18. The evidence for beta blockers in heart failure.BMJ (Clinical research ed.) · 1999
    Article
19. Clinical guidelines: using clinical guidelines.BMJ (Clinical research ed.) · 1999
    Review
20. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.BMJ (Clinical research ed.) · 1999
    Article

Corrections and comments

• Commented on by
  Aspirin prophylaxis for vascular disease. Knowledge needs to be used in clinical situations.1998

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as